Literature DB >> 35573143

Photodynamic therapy for peripapillary pachychoroid syndrome-a case report.

George J Manayath1, Shishir Verghese1, Ratnesh Ranjan1, Venkatapathy Narendran1.   

Abstract

A 76-year-old man presented with reduced visual acuity in both eyes, more severe in the right eye. His previous medical history included anti-vascular endothelial growth factor treatment, with multiple intravitreal injections in both eyes, and repeated focal laser in the left eye. His best-corrected visual acuity was 20/200 in the right eye and 20/40 in the left eye. Based on fundus examination and multimodal imaging, the patient was diagnosed with pachychoroid disease with peripapillary pachychoroid syndrome in the right eye and nasal macular scarring with late cystoid degeneration in the left eye. He underwent low-fluence photodynamic therapy in both eyes. At 6 months' follow-up, best-corrected visual acuity improved to 20/120 in the right eye and was maintained at 20/40 in the left eye, with good anatomical outcome.
Copyright ©2022. All rights reserved. Reproduction in whole or in part in any form or medium without expressed written permission of the Digital Journal of Ophthalmology is prohibited.

Entities:  

Mesh:

Year:  2021        PMID: 35573143      PMCID: PMC9070683          DOI: 10.5693/djo.02.2021.11.001

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  10 in total

Review 1.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

2.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 3.  System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.

Authors:  Jinlan Ma; Nana Meng; Xiaoyi Xu; Fang Zhou; Yi Qu
Journal:  Acta Ophthalmol       Date:  2014-07-13       Impact factor: 3.761

4.  Diagnosis by multimodal imaging in peripapillary pachychoroid syndrome: A case report.

Authors:  B Alonso-Martín; B de-Lucas-Viejo; M Gimeno-Carrero; M Ferro-Osuna; J Sambricio
Journal:  Arch Soc Esp Oftalmol (Engl Ed)       Date:  2020-03-18

5.  Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy.

Authors:  Takahiko Izumi; Hideki Koizumi; Ichiro Maruko; Yohei Takahashi; Shozo Sonoda; Taiji Sakamoto; Tomohiro Iida
Journal:  Br J Ophthalmol       Date:  2016-07-07       Impact factor: 4.638

6.  Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.

Authors:  Elodie Bousquet; Talal Beydoun; Min Zhao; Leila Hassan; Olivier Offret; Francine Behar-Cohen
Journal:  Retina       Date:  2013 Nov-Dec       Impact factor: 4.256

7.  Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.

Authors:  San-Ni Chen; Jiunn-Feng Hwang; Li-Fang Tseng; Chun-Ju Lin
Journal:  Ophthalmology       Date:  2008-12       Impact factor: 12.079

8.  PERIPAPILLARY PACHYCHOROID SYNDROME.

Authors:  Nopasak Phasukkijwatana; K Bailey Freund; Rosa Dolz-Marco; Mayss Al-Sheikh; Pearse A Keane; Catherine A Egan; Sandeep Randhawa; Jay M Stewart; Qingyun Liu; Alex P Hunyor; Allan Kreiger; Aaron Nagiel; Robert Lalane; Mansour Rahimi; Won Ki Lee; Lee M Jampol; David Sarraf
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

Review 9.  Pachychoroid disease.

Authors:  Chui Ming Gemmy Cheung; Won Ki Lee; Hideki Koizumi; Kunal Dansingani; Timothy Y Y Lai; K Bailey Freund
Journal:  Eye (Lond)       Date:  2018-07-11       Impact factor: 3.775

10.  Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.

Authors:  Cihan Ünlü; Gurkan Erdogan; Tugba Aydogan; Betul Ilkay Sezgin Akcay; Esra Kardes; Gulunay Akcali Kiray; Tahir Kansu Bozkurt
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.